Condition: Gestational Diabetes · Sponsor: National University of Malaysia
This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.
This description comes directly from the study's public registry record.
Rahana ARahman, MD · +60391455964 · drrahana@ukm.edu.my
Always discuss trial participation with your own doctor first.
| Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz | Cheras, Kuala Lumpur, Malaysia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06676254